ABSTRACT The development of isocyanate asthma is little understood. To gain more knowledge in this area, a group of 20 workers occupationally exposed to isocyanates, five subjects with clinical isocyanate asthma, and a control group of 10 people not exposed to isocyanate were examined with lung function tests and a methacholine provocation test. Forced expiratory volume in one second and tests aimed at detecting small airways obstruction such as volume of trapped gas, closing volume, and wash out volume were made. To detect abnormal airway reactivity, tests were made before and after inhalation of methacholine and of salbutamol. A significant increased reactivity to methacholine in the exposed and asthma groups was seen compared with the control group as measured by volume of trapped gas. The increase was reversed by inhaling salbutamol. In neither group could a statistically significant reaction be shown in the large airways. The study group had increased small airways reactivity of the same magnitude as the group with isocyanate asthma. The subjects in the study group had no clinical symptoms or spirometric abnormalities. The volume of trapped gas in combination with methacholine seems to disclose significantly altered reactivity of the small airways in workers exposed to isocyanate with no subjective symptoms of disease.
Isocyanates even at very low levels, have a sensitising effect on the airways' but most exposed workers have no respiratory symptoms related to their exposure.2 It has not been possible to establish any dose-response relation3 but about 10% of workers exposed to toluene diisocyanate (TDI) eventually develop asthma. 4 Exposure to TDI has been shown to give an annual decline in the forced expiratory flow (FEF25 -7 and FEF5o) that is greater than in an unexposed population.5 Irrespective of symptoms of asthma, workers exposed to TDI have an accelerated decline in lung function as measured by forced expiratory volume in one second (FEVy).6
Non-specific bronchial hyperreactivity is often found in patients with asthma due to isocyanates.7 Bronchial hyperreactivity seems also to be a risk factor for the development of chronic obstructive lung disease.8 Among patients with chronic obstructive lung disease small airway changes are often found.9
Patients with asthma often have a functional impairment of the small airways that is usually reversible after inhaling bronchodilating drugs. To detect provoked and rapidly reversible asthma in the small airways, FEV, and maximum flow at 25% of vital capacity have been found to be less sensitive than the Accepted 9 March 1987 volume of trapped gas (VTG). 0 Subjective symptoms may be absent until obstructive changes in large airways occur, since small airway disease does not increase resistance to breathing.
The purpose of the present study was to search for small airway hyperreactivity among symptom free workers exposed to isocyanate. The demonstration of hyperreactivity at very low exposure is important for the setting of hygienic limit values for isocyanates. Our hypothesis was that isocyanates might cause hyperreactivity in the small airways and that the changes in reactivity could be detected before any subjective symptoms had appeared.
The method used for measuring the VTG" has been shown to be sensitive to abnormalities in the small airways.12 By combining the VTG method with methacholine inhalation we hoped to increase the sensitivity for detecting abnormal reactivity in small airways. To study the reversibility of obstruction in small airways VTG was also measured before and after inhalation of the /2 agonist salbutamol (Ventoline, Glaxo).
Material
The study group (n = 20; 20-56 years) consisted of men exposed to isocyanates at their workplaces in 824
Small airway hyperreactivity among lifelong non-atopic non-smokers exposed to isocyanates Malmo. They had been exposed to isocyanates in different work procedures such as insulation of heating pipes, spray painting of vehicles, and polyurethane glueing. The local unions helped select the study group. They were informed that we wished to study workers with no respiratory symptoms. The union safety officers supplied us with lists of workers who had never smoked and were exposed to isocyanates. The size of the study group was limited by difficulties in finding workers who had never smoked. Initially 24 workers were referred, four of whom were not included in the final group. The reasons for exclusion were in one a family history of asthma and raised total IgE, in the second seven positive skin prick tests to common allergens, in the third pleurisy, past lung inflammation, and exposure to asbestos, and in the fourth inability to participate because of allergic symptoms.
The subjects in the study group all considered themselves healthy and had no respiratory symptoms. None had any history of asthma or other allergic disease or a family history of such diseases. They thus constituted a healthy sample of workers exposed to isocyanate.
The control group (n = 10; 24-41 years) comprised non-smoking men with no previous lung disease or history of asthma or allergy. They had no contact with isocyanates or other lung irritating agents. For the closing volume measurements, equipment failure reduced the control group to only three subjects.
We also re-examined five subjects (aged 19-48) diagnosed as having asthma induced or worsened by exposure to isocyanate. The diagnosis was made by clinical signs of asthma and at least 20% decrease of FEV, at methacholine inhalation. All were smokers and had been removed from further exposure to isocyanates for at least one year before the present examination and were free from symptoms of asthma at the time of examination.
The study and control groups were comparable with regard to age, height, and results of blood tests such as total IgE, eosinophil leukocytes, and total leukocytes.
The group with asthma had more eosinophil leukocytes (mean = 190* 106/1) than the control (mean = 77* 106/1) and study (mean = 104* 106/1) groups. The difference between the asthmatic group and the study group was not statistically significant (0-05 < p < 0-1). The asthmatic group also had higher values of total IgE (mean = 160 ku/1) than the study (mean = 45 ku/l) and the control (mean = 34 ku/l) groups but the differences were not statistically significant.
Standard skin prick testing was performed in the study group with a panel of 11 common allergens (Soluprick, Nordiskt Allergilaboratorium, Copenhagen). Diluent and histamine controls were made.
Testing showed weak 2 mm positive skin reaction to diluted (1:100) home dust in one subject and positive skin reactions to birch and common alder in another subject in the study group. Neither had a family history of asthma or allergy, no history of atopic manifestations, and both had normal total IgE (65 ku/I).
No positive skin prick test was found using albumin conjugated isocyanates. Nor 
Results
Before methacholine inhalation, VTG was equal in the three groups. After the inhalation of methacholine, VTG increased in both the study and asthmatic groups (table 1), indicating increased bronchial reactivity. After the inhalation of 0-001% methacholine the difference between the study and control groups was statistically significant (p < 0.05). The difference became larger with increasing methacholine concentrations and at inhalation of 1 % methacholine there was a large difference between the study and control groups (p < 0 001). The increase of VTG was reversed by inhaling salbutamol. The control group had only a slight increase in VTG after inhaling 1 % methacholine. No correlation was found between VTG and exposure time (Spearman's r = 0-23, p = 0-31). Small airway hyperreactivity among lifelong non-atopic non-smokers exposed to isocyanates Wilcoxon-Mann-Whitney test, no statistically significant difference in comparisons with the control group.
Washout volume also increased after methacholine inhalation but was significant only after the inhalation of 1% methacholine (table 2) . Closing volume, closing capacity, and slope index did not increase significantly in the study group. In the asthmatic group a slight increase was found after inhaling 1% methacholine compared with the controls (table 3) . No large airway hyperreactivity as studied by FEV1 was found in any of the groups, although the asthmatic group had a slight reaction at 1% methacholine. The reaction was reversed with salbutamol (table 4) . Regression of FEV1, corrected for age and height, on exposure time indicated a progressive lowering of FEV1 with an increase in exposure time. The correlation was not statistically significant (Spearman's r = 0-32, p = 0-17).
Discussion
Our main finding is the demonstration of increased VTG after the inhalation of methacholine in a group of non-atopic symptom free lifelong non-smokers exposed to isocyanates. The other methods used for the study of small airways, such as washout volume, closing volume, closing capacity, and slope index, confirmed the small airway hyperreactivity found in the study and asthmatic groups. Since the relative changes before and after methacholine provocation were larger for VTG, we conclude that this method is more sensitive in detecting hyperreactivity in small airways. Our results also indicate that closing volume and VTG may not measure the same function in the small airways. The short time reproducibility of VTG has an error for a single determination of 8 ml,"2 and in our laboratory is 12 ml in subjects with asthma (unpublished data).
Bronchial hyperreactivity was not found in the large airways, as measured by fall of FEV1. The fall did not exceed 20% after inhaling 1% or less methacholine. This is in agreement with studies showing lack of hyperreactivity in the large airways despite a history of occupational asthma due to TDI. Nevertheless, hyperreactivity could be shown after the subjects had been exposed to TDI by inhalation challenge.18 Such exposure, even under controlled conditions, certainly entails a greater risk than using the highly sensitive VTG determination in combination with a methacholine provocation test.
The exposed workers had no history of asthma or allergy. Subjects with raised total IgE and positive skin prick tests to several common allergens were not included, thus the study group is highly selected for non-atopic subjects. We included one subject in the study group with positive skin prick tests to two common allergens. His increase of VTG to methacholine provocation was equal to the mean increase in the 828 study group. As a sample, the exposed workers represent that part of the workforce exposed to isocyanate with healthy lungs, but they had nevertheless developed non-specific small airway hyperreactivity. The tendency to develop asthma is often hereditary but lack of a family history of asthma did not hinder the development of non-specific hyperreactivity.
The control group was considered to be a representative of a non-smoking non-allergic population but since the subjects were not skin prick tested, some with positive skin prick tests to common allergens might have been included.
The same degree of hyperreactivity in the small airways was present in both the symptom free nonsmoking isocyanate group and the group with previous isocyanate induced asthma. Our findings indicate that isocyanates, even at low exposures, must be considered a health hazard. Since we have controlled for smoking and allergy, we suggest that the observed difference in small airways reactivity is caused by exposure to isocyanates.
Three of the excluded subjects were tested with methacholine and all showed a pronounced increase in VTG. One of these symptom free subjects, who had a negative skin prick test but a raised total IgE (120 ku/1) and a mother with asthma, continued to be exposed to isocyanates and two years later developed clinical asthma. This indicates that increased VTG after methacholine provocation might be a predictor for the development of asthma.
This cross sectional study cannot predict that abnormal reactivity in the small airways in the study group may proceed to manifest obstructive lung disease. A prospective study among subjects exposed to isocyanate is necessary to determine whether such a risk exists. Nevertheless, the exposed workers, despite a lack of disease, had the same degree of hyperreactivity as the group with previously manifest isocyanate asthma.
Workers at risk from obstructive lung disease might be detected at a preclinical stage with a provocation test using methacholine and the subsequent determination of VTG. Understanding the early development of asthma is important, and more studies should be directed to diseases of small airways. It might be possible to prevent progression to clinical asthma or chronic obstructive lung disease. 
